Ohio State
Researchers are planning a clinical trial after four metastatic FGFR2 fusion-positive pancreatic cancer patients responded to FGFR-directed therapy.
Ohio State, Helix Launch Precision Health Initiative in Ohio
The study aims to enroll 100,000 individuals over four years and to provide participants with information about their potential risks for serious health conditions.
Some patients whose CLL turned into lymphoma had durable responses on autologous cell therapies, according to a retrospective analysis featured at the ASH annual meeting.
Expert Panel Publishes Guidelines for Genetic Testing, Counseling in ALS
Recommendations call for testing all people with ALS and seek to harmonize laboratory testing and reporting practices.
ASGCT Gene Therapy Clinical Trial Highlights From Pfizer, Rocket Pharma, OSU, Ultragenyx, and More
At the meeting, companies and academic centers shared early and long-term follow-up data on investigational gene therapies for DMD, Danon disease, AADC, and other rare diseases.